IDEAYA Biosciences
Mick O'Quigley is a seasoned professional in clinical operations and development, currently serving as Senior Vice President and Head of Development Operations at IDEAYA Biosciences since August 2018, with prior roles as Vice President and Head of Clinical Operations. O'Quigley's previous experience includes a decade at Genentech, where responsibilities spanned from Program Group Director for the Cancer Immunotherapy Portfolio to strategic oversight of the Cell Signaling Portfolio. Earlier, O'Quigley held the position of Sr Manager in Medical Research at Amgen, providing clinical operations oversight for Vectibix trials. O'Quigley holds an MBA from Pepperdine Graziadio Business School and a BA in Medicine from Trinity College Dublin.
This person is not in any offices
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California